in this issue
Regions :: North Asia :: Japan
Dr. Reddy's and Fujifilm call off JV for generic drugs in Japan, to explore opportunities in APIs
June 3, 2013 | Deepti Ramesh
Dr. Reddy’s Laboratories (Hyderabad, India) and Fujifilm (Tokyo) have decided to terminate their previously announced agreement for an exclusive partnership in the generic drugs business in the Japanese market via a joint venture in Japan, the companies announced today. Dr. Reddy’s and Fujifilm signed an memorandum of understanding (MOU) in July 2011 to establish a jv in Japan for manufacturing finished generic drugs for the Japanese market. It was agreed that Fujifilm would hold a 51% stake in the jv, and Dr. Reddy’s would hold the rest. The...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee